ARTICLES BY ABBY PROCH

• What Sites, Sponsors, Vendors, And CROs Can All Agree On

  4/17/2026

  Experts representing sponsors, sites, vendors, and CROS discussed at Life Sciences Future SW the pain points and the opportunities that lie ahead in clinical research.

• The Latest On RBM Uptake? Tufts Says Most, But Not All, Pharma On Board

  3/5/2026

  Tufts CSDD’s Beth Harper shares findings from the org's latest Impact Report and discusses how companies might better define risk, measure success, and understand central monitoring. 

• Pick The Right PV Technology With Help From A Safety Data Management Expert

  2/27/2026

  Otsuka's Head of U.S. GPV Safety Data Management Vikalp Khare shares how smart governance should inform pharmacovigilance (PV) technology choices.

• Heard At SCOPE: Pharma Wants ROI For Patient Data Return, Diverse Enrollment

  2/11/2026

  Twice I heard “ROI is the elephant in the room.” Two different panel discussions, two different tracks. 

• Becoming A Backbone Therapy: Lessons Learned With Actuate Therapeutics

  2/5/2026

  CEO Dan Schmitt discusses the pursuit of a backbone therapy and how Actuate's current and planned trials are structured to confirm that potential.

• 3 Clinical Research Attorneys Talk 2026 Trends

  1/23/2026

  Three life sciences legal experts share what they see happening in the year ahead — and what should remain firmly in the past. 

• Digital Protocols Are At An Inflection Point: A Conversation With Novartis And TransCelerate Leaders

  1/23/2026

  Digital protocols could reduce manual effort and enable rapid and more consistent downstream study execution, reporting, and submission processes. TransCelereate BioPharma's Rob DiCicco and Novartis' Bill Illis explain.

• "Study Within A Study" Reveals Best Recruitment Strategies For Alzheimer's Trials

  1/20/2026

  In this Q&A, Acumen Pharmaceuticals shares findings from its Alzheimer's recruitment study, highlighting what efforts proved the most fruitful.

• Endpoints, Procedures, And Deviations Are On The Rise — Why?

  1/20/2026

  SCRS Chief Site Success Officer Jimmy Bechtel, MBA, and Tufts CSDD Executive Director Ken Getz, MBA, discuss why they're on the rise explore ways to address, and even accept, them. 

• Could Moving To This Swiss Life Sciences Hub Be In Your Company's Future?

  1/15/2026

  Basel Area Business & Innovation CEO Christof Klöpper discusses how the Basel Area Life Sciences Supercluster supports discovery through commercialization.

• Working (Well) With Patient Advocates: The Sponsor POV

  1/12/2026

  Aeovian CEO Allison Hulme reflects on Aeovian Pharmaceuticals' partnership with the TSC Alliance and how it’s informed research and development of their first-in-class selective mTORC1 inhibitor. 

• Working (Successfully) With Pharma: A PAG's Perspective

  1/12/2026

  TSC Alliance President and CEO Kari Rosbeck details the patient advocacy group's unique and fruitful relationship with Aeovian Pharmaceuticals in developing the company's first-in-class selective mTORC1 inhibitor for TSC-related refractory epilepsy.

• How Should Scientific Focus Change In 2026? Researchers Weigh In

  1/8/2026

  To kick off 2026, clinical researchers share how they think research should change in the new year.

• Researchers Want A Design Shake-Up In 2026

  1/7/2026

  When asked what clinical research professionals should leave behind in 2025, quite a few lamented the stale, even problematic, approach to clinical trial design. Here's what they want done differently in 2026.

• No Surprise Here: Experts Value Clinical Relevance Over Statistical Relevance

  12/31/2025

  Experts weighed in: “Agree or disagree? Statistical significance is preferable to clinical relevance.”

• Trial Matching, Source Data, And More: How Clinical Researchers Used AI In 2025

  12/30/2025

  Researchers reflect on the past year and share how they used AI for clinical research in 2025.

• What Can We Expect From The FDA In 2026?

  10/20/2025

  Expert panelists at the 2025 RAPS Convergence discussed what lies ahead for the FDA in 2026.

• Diverse Enrollment — Ahem, "Biological Variability" — Gets Widespread Support At RAPS Convergence

  10/16/2025

  DEI, diverse enrollment, biological variability -- whatever you call it, industry leaders at RAPS Convergence discussed their unwavering support of it when it comes to executing clinical trials that align "good science" with "the right thing to do."

• What Sites Wish Tech Vendors (And Sponsors) Heard At SCDM But Probably Didn't

  10/8/2025

  During a Society for Clinical Data Management (SCDM) panel discussion, three site-side representatives discussed the challenges clinical research coordinators have executing their clinical duties amid increasingly complex data entry demands.

• SCDM 2025: Practical Advice From Global Regulators — Including The FDA

  10/6/2025

  Discover what regulators from around the world, including the FDA, think should be top of mind for clinical data managers.

• Celebrating Clinical Trials Day, Part 2: Trial Optimization In Action

  5/20/2025

  Celebrate Clinical Trials Day 2025 with these industry experts as they share experiences and advice related to trial design, regulatory and compliance, and outsourcing challenges.

• Celebrating Clinical Trials Day, Part 1: Putting The Patient First

  5/20/2025

  Celebrate Clinical Trials Day 2025 with these industry experts sharing their experiences and advice for putting the patient first.

• Celebrating Clinical Trials Day, Part 3: Making The Most Of Resources

  5/20/2025

  Celebrate Clinical Trials Day 2025 with these industry experts, who share their experiences in and advice for establishing partnerships and finding the best talent.

• Annual SCOPE Summit Serves Up A Similar But Satisfying Menu

  2/7/2025

  Executive editor Abby Proch sums up her second SCOPE Summit experience.

• 4 Perspectives On What's Next In Clinical Trial Tech

  12/12/2024

  Clinical Leader asked clinical research professionals: “Internal, external, patient-facing, or otherwise — what clinical trial tech tool are you most excited to embrace or ditch in the new year? And why?”

• Where Do We Stand With DCTs Heading Into 2025?

  12/9/2024

  Clinical Leader asked familiar voices and new faces alike: “What’s left to say, to understand, or to do with DCTs (or elements thereof) in 2025?”

• How Did Clinical Researchers Actually Use AI In 2024?

  12/5/2024

  Looking ahead to 2025, Clinical Leader seeks to understand how clinical research professionals are incorporating AI into their work. So we asked them, “Simply put: Are you using any iteration of AI in your role within clinical research? If so, how and why?”

• Psychedelic Community Reacts To FDA Committee's Critique Of Lykos' MDMA Studies

  6/14/2024

  An FDA advisory committee rejected the validity of therapy-assisted MDMA clinical trials conducted for the treatment of PTSD. What does the committee’s vote mean for the pursuit of MDMA and other psychedelic therapies?

• The Best Advice I Ever Got: On The Job

  5/22/2024

  To commemorate Clinical Trials Day 2024, Clinical Leader tapped its community of clinical research professionals to share their insights — from individual efforts to partnership best practices to trial design and more.

• The Best Advice I Ever Got: Patient Centricity

  5/21/2024

  To commemorate Clinical Trials Day 2024, Clinical Leader heard from those most invested in and concerned with keeping the patient as the focus.

• The Best Advice I Ever Got: Networking

  5/20/2024

  To commemorate Clinical Trials Day 2024, Clinical Leader tapped its community of clinical research professionals to share their experiences with and praise for working with one another across the industry.

• 4 Things I Learned At SCOPE 2024

  2/21/2024

  The Summit for Clinical Ops Executives (SCOPE) ran from Feb. 11-4. Discover four things Executive Editor Abby Proch learned at the annual event.

• 4 Things I'm Looking Forward To At SCOPE 2024

  2/1/2024

  The Summit for Clinical Ops Executives (SCOPE) begins Feb. 11. Discover four things Executive Editor Abby Proch is looking forward to at the annual event.

• What Clinical Trial Experts Think Will Happen With DCTs In 2024

  12/28/2023

  In part three of this preview of clinical trials trends, experts discuss the state of decentralized trials in all their permutations and muse on their fates as we enter 2024. 

• What Experts Think Will Happen With Patient Centricity In 2024

  12/27/2023

  In part two, experts discuss patient centricity themes, including diversity, equity, and inclusion (DEI) and precision medicine, in the clinical trials industry as we move into 2024.

• What Clinical Trial Experts Think Will Happen With AI In 2024

  12/26/2023

  In part one of this preview of clinical trials trends for 2024, experts discuss the applications of AI in clinical research.